Associated Papers
The preclinical discovery and development of edaravone for the treatment of amyotrophic lateral sclerosis: what lessons have we learnt?
Charbonnel T et al.
Expert Opinion on Drug Discovery, 2026
Drug Screening and Validation Targeting TDP-43 Proteinopathy for Amyotrophic Lateral Sclerosis.
Xin J et al.
Aging and Disease, 2024
A Novel Drosophila-based Drug Repurposing Platform Identified Fingolimod As a Potential Therapeutic for TDP-43 Proteinopathy.
Lo Piccolo L et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics, 2023
Select a paper to view details